Standout Papers

Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis pat... 2015 2026 2018 2022 260
  1. Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients (2015)
    Lisa Rice, Cristina M. Padilla et al. Journal of Clinical Investigation

Immediate Impact

1 by Nobel laureates 4 from Science/Nature 60 standout
Sub-graph 1 of 21

Citing Papers

TGF-β signaling in health, disease and therapeutics
2024 Standout
NLRC5 senses NAD+ depletion, forming a PANoptosome and driving PANoptosis and inflammation
2024 Standout
1 intermediate paper

Works of Sarah McLaughlin being referenced

Signatures of malaria-associated pathology revealed by high-resolution whole-blood transcriptomics in a rodent model of malaria
2017
Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients
2015 Standout

Author Peers

Author Last Decade Papers Cites
Sarah McLaughlin 308 153 299 158 17 767
I Katayama 255 75 183 147 32 776
Krishna K. Yelavarthi 605 192 110 131 13 944
Donald J. Innes 148 95 328 130 29 907
Marjatta Sinisalo 302 73 176 70 32 920
P Herzog 129 163 550 80 16 809
AM Levine 202 142 295 227 22 880
Berger Cl 390 87 226 60 22 758
Kathrin Seidemann 108 253 322 162 26 929
Riccardo Navone 232 30 201 169 12 820
Jehan Alam 136 205 239 143 27 776

All Works

Loading papers...

Rankless by CCL
2026